Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.

Ruggiero RN, Rossignoli MT, De Ross JB, Hallak JEC, Leite JP, Bueno-Junior LS.

Front Pharmacol. 2017 Jun 21;8:399. doi: 10.3389/fphar.2017.00399. eCollection 2017. Review.

2.

New paradigm for auditory paired pulse suppression.

Takeuchi N, Sugiyama S, Inui K, Kanemoto K, Nishihara M.

PLoS One. 2017 May 18;12(5):e0177747. doi: 10.1371/journal.pone.0177747. eCollection 2017.

3.

Animal models to improve our understanding and treatment of suicidal behavior.

Gould TD, Georgiou P, Brenner LA, Brundin L, Can A, Courtet P, Donaldson ZR, Dwivedi Y, Guillaume S, Gottesman II, Kanekar S, Lowry CA, Renshaw PF, Rujescu D, Smith EG, Turecki G, Zanos P, Zarate CA Jr, Zunszain PA, Postolache TT.

Transl Psychiatry. 2017 Apr 11;7(4):e1092. doi: 10.1038/tp.2017.50. Review.

4.

Investigating Cortical Inhibition in First-Degree Relatives and Probands in Schizophrenia.

Radhu N, Dominguez LG, Greenwood TA, Farzan F, Semeralul MO, Richter MA, Kennedy JL, Blumberger DM, Chen R, Fitzgerald PB, Daskalakis ZJ.

Sci Rep. 2017 Feb 27;7:43629. doi: 10.1038/srep43629.

5.

P300 and neuropsychological measurements in patients with schizophrenia and their healthy biological siblings.

Raghavan DV, Shanmugiah A, Bharathi P, Jeyaprakash R.

Indian J Psychiatry. 2016 Oct-Dec;58(4):454-458. doi: 10.4103/0019-5545.196709.

6.

Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia.

Thomas ML, Green MF, Hellemann G, Sugar CA, Tarasenko M, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Shiluk AL, Siever LJ, Silverman JM, Sprock J, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL, Light GA.

JAMA Psychiatry. 2017 Jan 1;74(1):37-46. doi: 10.1001/jamapsychiatry.2016.2980.

PMID:
27926742
7.

Reduced Prepulse Inhibition as a Biomarker of Schizophrenia.

Mena A, Ruiz-Salas JC, Puentes A, Dorado I, Ruiz-Veguilla M, De la Casa LG.

Front Behav Neurosci. 2016 Oct 18;10:202. eCollection 2016.

8.

Amphetamine Enhances Gains in Auditory Discrimination Training in Adult Schizophrenia Patients.

Swerdlow NR, Tarasenko M, Bhakta SG, Talledo J, Alvarez AI, Hughes EL, Rana B, Vinogradov S, Light GA.

Schizophr Bull. 2016 Oct 25. pii: sbw148. [Epub ahead of print]

PMID:
27798224
9.

Temporal Lobe Volume Decrements in Psychosis Spectrum Youths.

Roalf DR, Quarmley M, Calkins ME, Satterthwaite TD, Ruparel K, Elliott MA, Moore TM, Gur RC, Gur RE, Moberg PJ, Turetsky BI.

Schizophr Bull. 2017 May 1;43(3):601-610. doi: 10.1093/schbul/sbw112.

PMID:
27559077
10.

Mismatch Negativity to Threatening Voices Associated with Positive Symptoms in Schizophrenia.

Chen C, Liu CC, Weng PY, Cheng Y.

Front Hum Neurosci. 2016 Jul 15;10:362. doi: 10.3389/fnhum.2016.00362. eCollection 2016.

11.

The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia.

Bristow LJ, Easton AE, Li YW, Sivarao DV, Lidge R, Jones KM, Post-Munson D, Daly C, Lodge NJ, Gallagher L, Molski T, Pieschl R, Chen P, Hendricson A, Westphal R, Cook J, Iwuagwu C, Morgan D, Benitex Y, King D, Macor JE, Zaczek R, Olson R.

PLoS One. 2016 Jul 28;11(7):e0159996. doi: 10.1371/journal.pone.0159996. eCollection 2016.

12.

From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia.

Cariaga-Martinez A, Saiz-Ruiz J, Alelú-Paz R.

Front Neurosci. 2016 May 11;10:202. doi: 10.3389/fnins.2016.00202. eCollection 2016. Review.

13.

A Meta-analytic Review of Auditory Event-Related Potential Components as Endophenotypes for Schizophrenia: Perspectives From First-Degree Relatives.

Earls HA, Curran T, Mittal V.

Schizophr Bull. 2016 Nov;42(6):1504-1516. doi: 10.1093/schbul/sbw047. Epub 2016 May 23. Review.

PMID:
27217271
14.

Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study.

Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, Siever L, Silverman J, Stone WS, Sprock J, Sugar CA, Swerdlow NR, Tsuang M, Turetsky B, Radant A, Tsuang DW.

Schizophr Res. 2016 Jul;174(1-3):1-9. doi: 10.1016/j.schres.2016.04.011. Epub 2016 Apr 28.

15.

Electrophysiological Endophenotypes for Schizophrenia.

Owens EM, Bachman P, Glahn DC, Bearden CE.

Harv Rev Psychiatry. 2016 Mar-Apr;24(2):129-47. doi: 10.1097/HRP.0000000000000110. Review.

16.

Functional Effects of Schizophrenia-Linked Genetic Variants on Intrinsic Single-Neuron Excitability: A Modeling Study.

Mäki-Marttunen T, Halnes G, Devor A, Witoelar A, Bettella F, Djurovic S, Wang Y, Einevoll GT, Andreassen OA, Dale AM.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Jan 1;1(1):49-59.

17.

Animal Models of Maladaptive Traits: Disorders in Sensorimotor Gating and Attentional Quantifiable Responses as Possible Endophenotypes.

Vargas JP, Díaz E, Portavella M, López JC.

Front Psychol. 2016 Feb 19;7:206. doi: 10.3389/fpsyg.2016.00206. eCollection 2016. Review.

18.

Event-related potentials elicited by the Deutsch "high-low" word illusion in the patients with first-episode schizophrenia with auditory hallucinations.

Xu Y, Chai H, Zhang B, Gao Q, Fan H, Zheng L, Mao H, Zhang Y, Wang W.

BMC Psychiatry. 2016 Feb 18;16:33. doi: 10.1186/s12888-016-0747-3.

19.

Large-Scale Fusion of Gray Matter and Resting-State Functional MRI Reveals Common and Distinct Biological Markers across the Psychosis Spectrum in the B-SNIP Cohort.

Wang Z, Meda SA, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, Schretlen DJ, Calhoun VD, Lui S, Pearlson GD.

Front Psychiatry. 2015 Dec 21;6:174. doi: 10.3389/fpsyt.2015.00174. eCollection 2015.

20.

Molecular cause and functional impact of altered synaptic lipid signaling due to a prg-1 gene SNP.

Vogt J, Yang JW, Mobascher A, Cheng J, Li Y, Liu X, Baumgart J, Thalman C, Kirischuk S, Unichenko P, Horta G, Radyushkin K, Stroh A, Richers S, Sahragard N, Distler U, Tenzer S, Qiao L, Lieb K, Tüscher O, Binder H, Ferreiros N, Tegeder I, Morris AJ, Gropa S, Nürnberg P, Toliat MR, Winterer G, Luhmann HJ, Huai J, Nitsch R.

EMBO Mol Med. 2016 Jan 1;8(1):25-38. doi: 10.15252/emmm.201505677.

Supplemental Content

Support Center